Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-95.40
↓ 180% vs avg
Percentile
P13
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-34.03
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -95.40 | -1913.2% |
| 2024 | -4.74 | -1166.1% |
| 2023 | -0.37 | +84.5% |
| 2022 | -2.41 | +72.2% |
| 2021 | -8.67 | +75.6% |
| 2020 | -35.53 | -295.3% |
| 2019 | -8.99 | +77.2% |
| 2018 | -39.45 | +64.4% |
| 2017 | -110.71 | - |